Nautilus Biotechnology, Inc.
NAUT
$0.6884
-$0.0246-3.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -70.78M | -70.21M | -69.64M | -67.44M | -63.68M |
| Total Depreciation and Amortization | 6.35M | 6.39M | 6.26M | 6.13M | 5.71M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.74M | 9.86M | 9.87M | 9.65M | 9.48M |
| Change in Net Operating Assets | -5.46M | -4.77M | -3.85M | -3.79M | -3.22M |
| Cash from Operations | -59.15M | -58.74M | -57.36M | -55.45M | -51.71M |
| Capital Expenditure | -2.88M | -2.28M | -2.45M | -2.40M | -2.44M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.13M | -9.64M | 11.11M | -5.49M | -41.29M |
| Cash from Investing | 66.25M | -11.92M | 8.66M | -7.89M | -43.74M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.14M | 957.00K | 833.00K | 612.00K | 368.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.14M | 957.00K | 833.00K | 612.00K | 368.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.25M | -69.70M | -47.87M | -62.73M | -95.08M |